Chih-Hsin Lee
Overview
Explore the profile of Chih-Hsin Lee including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
95
Citations
716
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nguyen V, Duong H, Lee M, Chen J, Huang W, Chen H, et al.
J Infect Public Health
. 2025 Mar;
18(5):102711.
PMID: 40024220
Background: Mycobacterium avium complex (MAC) infection, requiring prolonged treatment with an antibiotic combination, is an emerging public health concern. Methods: This meta-analysis compared the efficacy of 2-drug regimens with that...
2.
Nguyen V, Lin H, Lee W, Ju K, Dai J, Hsieh P, et al.
Expert Rev Respir Med
. 2025 Feb;
:1-11.
PMID: 39943806
Background: NT-proBNP, traditionally used to assess heart failure, is increasingly recognized for its prognostic value in other diseases. This study evaluates its value in pneumonia. Research Design And Methods: We...
3.
Lee M, Keng L, Lee M, Chen J, Lee C, Wang J
Emerg Microbes Infect
. 2024 Oct;
13(1):2417855.
PMID: 39404086
Isoniazid is an early bactericidal anti-tuberculosis (TB) agent and isoniazid mono-resistance TB is the most prevalent drug-resistant TB worldwide. Concerns exist regarding whether resistance to isoniazid would lead to delayed...
4.
Chou C, Cheng C, Lee C, Kuro-O M, Chen T, Wang S, et al.
J Microbiol Immunol Infect
. 2024 Oct;
58(1):27-37.
PMID: 39395903
Background: Hemodialysis patients exhibit a reduced response to vaccination and have different vaccine dose regimens. Vaccines induce antibodies and affect the inflammatory balance through antibody glycosylation and effector functions. Therefore,...
5.
Huang H, Lee M, Lee C, Wang J
Clin Microbiol Infect
. 2024 Aug;
30(11):1482-1483.
PMID: 39173876
No abstract available.
6.
Lin C, Chen J, Chien S, Huang Y, Lin C, Lee J, et al.
J Microbiol Immunol Infect
. 2024 Aug;
57(5):791-800.
PMID: 39160114
Background: Bedaquiline, delamanid and fluoroquinolones are associated with increased QTcF. Whether clofazimine is associated with QTcF prolongation is less clear. Methods: All patients with rifampicin-resistant TB enrolled between May 2017...
7.
Huang H, Lee M, Lee C, Cheng M, Lu P, Sheu C, et al.
Clin Microbiol Infect
. 2024 Jul;
30(11):1410-1417.
PMID: 38996972
Objectives: The weekly rifapentine plus isoniazid for 3 months (3HP) improves completion rate of latent tuberculosis infection treatment, but flu-like symptoms are common. The novel 1HP regimen, involving daily rifapentine...
8.
Chen J, Lee M, Yen T, Huang P, Lu D, Lee C, et al.
Ann Acad Med Singap
. 2024 Jun;
53(2):69-79.
PMID: 38920231
Introduction: Few real-world studies have investigated drug-drug interactions (DDIs) involving non-vitamin-K antagonist oral anticoagulants (NOACs) in patients with nonvalvular atrial fibrillation (NVAF). The interactions encompass drugs inducing or inhibiting cytochrome...
9.
Liu W, Feng P, Cheng C, Chou C, Lee C, Lu M, et al.
Infect Dis Ther
. 2024 May;
13(7):1575-1588.
PMID: 38771550
Introduction: Ropeginterferon alfa-2b is a novel mono-pegylated proline-interferon. This clinical study aimed to evaluate its antiviral efficacy of ropeginterferon alfa-2b against SARS-CoV-2 infection. Methods: This is a multicenter, randomized, open-label...
10.
Huang Y, Yu M, Lin C, Lee J, Lin C, Chien S, et al.
J Microbiol Immunol Infect
. 2024 May;
57(4):617-628.
PMID: 38705821
Background: Pre-extensively drug-resistant tuberculosis (pre-XDR-TB), defined as multidrug-resistant TB (MDR-TB) with additional resistance to any fluoroquinolone (FQ) is difficult to treat. We assessed whether the use of new or repurposed...